Following their official visits to the Ministry of Health and Population, the Egyptian Authority for Unified Procurement (UPA), and the Egyptian Drug Authority (EDA), we were honored to welcome a high-level delegation from the International Vaccine Institute (IVI) to the Vaccine & Biotechnology City (VBC) headquarters today.
This visit marks a pivotal step in aligning VBC’s mission with global health standards. During the meeting, we presented our comprehensive R&D roadmap and shared our vision for the future of biotechnology in the region.
The discussions focused on exploring strategic, multi-pillar areas of cooperation, aimed at bridging VBC’s research and manufacturing capabilities with IVI’s world-class expertise in vaccine development and delivery.
By fostering these international dialogues, VBC continues to strengthen its position as a vital contributor to the national and global health landscape. We look forward to the potential synergies that will emerge from this exchange, driving innovation and securing a healthier future for all.
